Verdence Capital Advisors’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,786
| Closed | -$48.8K | – | 587 |
|
|
2023
Q4 | $48.8K | Buy |
10,786
+368
| +4% | +$1.66K | ﹤0.01% | 560 |
|
|
2023
Q3 | $37.3K | Sell |
10,418
-895
| -8% | -$3.2K | ﹤0.01% | 552 |
|
|
2023
Q2 | $41.7K | Buy |
11,313
+784
| +7% | +$2.89K | ﹤0.01% | 528 |
|
|
2023
Q1 | $34.9K | Sell |
10,529
-1,419
| -12% | -$4.7K | ﹤0.01% | 530 |
|
|
2022
Q4 | $46.4K | Buy |
+11,948
| New | +$46.4K | 0.01% | 491 |
|